GlassScriptPhysician profile
Shawn P Johnston
NPI 1699746941
$663.00
in general payments reported to CMS, 2019-2025
14 companies · $137 in 2025
The $137 reported for 2025 was less than what a typical Pain Medicine (Physical Medicine & Rehabilitation) provider received nationally (typical 2025 total: $400).
See the full distribution for Pain Medicine (Physical Medicine & Rehabilitation)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $47.75 · 2022: $256 · 2023: $119 · 2024: $103 · 2025: $137.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $359.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $358.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merz Pharmaceuticals, LLC | $142.13 | 2022-2025 | Xeomin |
| Abbvie INC. | $65.84 | 2022-2024 | |
| Abbott Laboratories | $62.16 | 2021-2024 | Proclaim |
| Collegium Pharmaceutical, INC. | $60.58 | 2023-2025 | Belbuca, Xtampza |
| Pfizer INC. | $57.06 | 2024-2025 | |
| Medtronic, INC. | $54.38 | 2022-2025 | Intellis Adaptivestim, Accurian |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $51.07 | 2022 | |
| Nevro Corp. | $39.81 | 2022 | |
| Lundbeck LLC | $35.43 | 2023-2025 | Vyepti |
| Lilly USA, LLC | $28.65 | 2022 | |
| Si-Bone, INC. | $17.50 | 2022 | |
| Teva Pharmaceuticals USA, INC. | $17.20 | 2023 | Ajovy |
| Grt US Holding, INC. | $16.34 | 2022 | |
| Averitas Pharma INC. | $14.85 | 2024 | Qutenza |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Shawn Johnston listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.